Point72 Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,524,485
Closed -$48.7M 1474
2022
Q2
$48.7M Buy
1,524,485
+604,285
+66% +$19.3M 0.21% 123
2022
Q1
$31.9M Buy
920,200
+736,729
+402% +$25.5M 0.13% 195
2021
Q4
$5.37M Sell
183,471
-2,129,129
-92% -$62.3M 0.02% 609
2021
Q3
$58.9M Buy
2,312,600
+251,000
+12% +$6.4M 0.26% 78
2021
Q2
$72.2M Buy
2,061,600
+736,118
+56% +$25.8M 0.32% 61
2021
Q1
$54M Buy
1,325,482
+1,272,802
+2,416% +$51.9M 0.25% 91
2020
Q4
$2.28M Buy
+52,680
New +$2.28M 0.01% 669
2020
Q3
Sell
-214,113
Closed -$13.5M 1097
2020
Q2
$13.5M Sell
214,113
-73,304
-26% -$4.63M 0.09% 264
2020
Q1
$14.7M Sell
287,417
-177,264
-38% -$9.06M 0.12% 242
2019
Q4
$36.9M Sell
464,681
-243,127
-34% -$19.3M 0.19% 146
2019
Q3
$34.3M Buy
+707,808
New +$34.3M 0.21% 132
2018
Q3
Sell
-435,900
Closed -$19.7M 1107
2018
Q2
$19.7M Buy
+435,900
New +$19.7M 0.08% 239
2018
Q1
Sell
-226,300
Closed -$8.91M 993
2017
Q4
$8.91M Sell
226,300
-1,796,400
-89% -$70.7M 0.04% 384
2017
Q3
$62.8M Buy
2,022,700
+1,323,934
+189% +$41.1M 0.28% 72
2017
Q2
$19.1M Buy
698,766
+287,666
+70% +$7.87M 0.11% 218
2017
Q1
$15.1M Buy
+411,100
New +$15.1M 0.08% 277
2016
Q2
Sell
-112,300
Closed -$1.78M 835
2016
Q1
$1.78M Buy
+112,300
New +$1.78M 0.01% 511